Top Things to Know About First Sustained-Release Glaucoma Me
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
The field of glaucoma just hit a major milestone: In March, the Food and Drug Administration approved the first sustained-release, intraocular pressure (IOP)-lowering implant (bimatoprost SR; Durysta). The implant will hopefully be available for use in June. Sustained-release medication is a burgeoning field, and we are optimistic it will transform the treatment paradigm for glaucoma and reduce the burden on patients.

Future seems bright with experimental sustained-release options that range from external rings, punctal plugs, gel-forming drops, subconjunctival and intrascleral implants, injectable agents and intracameral implants.

Some insights about the Sustained-Release Glaucoma Medication are given in the posters attached.

Source: https://www.aao.org/young-ophthalmologists/yo-info/article/top-7-things-to-know-about-first-sustained-release
pic credit: sciencedirect.com
Dr. T●●●●z H●●●●●●i and 4 others like this3 shares
Like
Comment
Share